Ibrutinib, the first-generation Bruton tyrosine kinase inhibitor, has well-documented cardiovascular effects that influence treatment decisions for patients with chronic lymphocytic leukemia. This quiz...
The AHA, ACC, and HRS recently released a focused update of their 2014 guidelines on atrial fibrillation management. Test your knowledge of the recommendations by taking this pop quiz.
Test your knowledge of the updated American Heart Association, American College of Cardiology, and Heart Rhythm Society guidelines for atrial fibrillation management by taking this pop quiz.
